Publications by authors named "Joe Horton"

Claim this Profile
D
Dolutegravir + Lamivudine vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies.
Mark Underwood, Rimgaile Urbaityte, Ruolan Wang, Joe Horton, James Oyee

Viruses· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction for Underwood et al., "Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study".
Mark Underwood, Joe Horton, Keith Nangle, Judy Hopking, Kimberly Smith

Antimicrob Agents Chemother· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study.
Mark Underwood, Joe Horton, Keith Nangle, Judy Hopking, Kimberly Smith

Antimicrob Agents Chemother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multistate trial of pharmacy syringe purchase.
Wilson M Compton, Joe C Horton, Linda B Cottler, Robert Booth, Carl G Leukefeld

J Urban Health· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist ambivalence about sale of syringes to injection drug users.
Wendy Reich, Wilson M Compton, Joe C Horton, Linda B Cottler, Renee M Cunningham-Williams

J Am Pharm Assoc (Wash)· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis